Bincy P. Abraham, MD

Professor of Clinical Medicine, Fondren Distinguished Professor in Inflammatory Bowel Disease, and Gastroenterology Fellowship Program Director, Department of Medicine
Houston Methodist
Weill Cornell Medical College


Biography

Bincy P. Abraham, MD, MS, is professor of clinical medicine in the Academic Division of Gastroenterology and Hepatology at Houston Methodist – Weill Cornell in Houston, Texas.

Dr. Abraham earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.

Description of Research

Dr. Abraham is a principal investigator and coinvestigator in several key clinical trials. As author or coauthor, Dr. Abraham’s work has been published in peer-reviewed medical journals including Clinical Gastroenterology and Hepatology, American Journal of Gastroenterology, and Inflammatory Bowel Diseases.

Areas Of Expertise

Crohn's disease Pregnancy & inflammatory bowel disease Transition of care in inflammatory bowel disease Ulcerative colitis
Publications

AGA Clinical Practice Update on the Role of Intestinal Ultrasound in Inflammatory Bowel Disease: Commentary
Chavannes, M, Dolinger, MT, Cohen-Mekelburg, S & Abraham, B 2024, , Clinical Gastroenterology and Hepatology, vol. 22, no. 9, pp. 1790-1795.e1. https://doi.org/10.1016/j.cgh.2024.04.039

Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis
Ouranos, K, Saleem, H, Vassilopoulos, S, Vassilopoulos, A, Mylona, EK, Shehadeh, F, Kalligeros, M, Abraham, BP & Mylonakis, E 2024, , Inflammatory bowel diseases. https://doi.org/10.1093/ibd/izae031

Therapeutic drug monitoring in inflammatory bowel disease patients on vedolizumab
Ansari, M, Glassner, K, Irani, M, Saleh, A, Wang, L, Ezeana, C, Wong, S, Perry, C & Abraham, B 2024, , Journal of Digestive Diseases, vol. 25, no. 2, pp. 91-99. https://doi.org/10.1111/1751-2980.13261

Role of the industry representative in the practice of gastroenterology and GI endoscopy
(ASGE ARIA Committee Chair) 2024, , Gastrointestinal Endoscopy, vol. 99, no. 3, pp. 307-313. https://doi.org/10.1016/j.gie.2023.10.057

Therapeutic drug monitoring in patients with inflammatory bowel disease on ustekinumab
Saleh, A, Stading, R, Miroballi, N, Glassner, K & Abraham, BP 2024, , Journal of Digestive Diseases, vol. 25, no. 4, pp. 214-221. https://doi.org/10.1111/1751-2980.13264

Postoperative Ustekinumab Drug Levels and Disease Activity in Patients with Crohn’s Disease
Moskow, J, Thurston, T, Saleh, A, Shah, A, Abraham, BP & Glassner, K 2024, , Digestive Diseases and Sciences, vol. 69, no. 8, pp. 2944-2954. https://doi.org/10.1007/s10620-024-08471-0

WHAT IS THE ROLE OF PROBIOTICS FOR PATIENTS WITH IBD?
Glassner, K & Abraham, BP 2024, in Curbside Consultation in IBD: 49 Clinical Questions. CRC Press, pp. 143-147. https://doi.org/10.1201/9781003523567-28

Irritable Bowel Syndrome in Women With IBD
Abraham, BP, Glassner, KL & Quigley, EM 2024, . in Women’s Health in IBD: The Spectrum of Care From Birth to Adulthood. CRC Press, pp. 195-212.

Women’s Health in IBD: The Spectrum of Care From Birth to Adulthood
Abraham, BP, Kane, SV & Glassner, KL 2024, . CRC Press. https://doi.org/10.1201/9781003526957

Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication
Maconi, G, Lepore, F, Saleh, A, Saibeni, S, Bezzio, C, Cheli, S, Massari, A, Gridavilla, D, Ferretti, F, Cannatelli, R, Ardizzone, S, Clementi, E & Abraham, B 2024, , Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.05.026

Development of Shingles on Tofacitinib Despite Completion of Recombinant Varicella-Zoster Virus Vaccine Series
Thomas, B, Moskow, J, Garza, M, Warren, B, Abraham, B & Glassner, K 2023, , ACG case reports journal, vol. 10, no. 12, pp. e01221. https://doi.org/10.14309/crj.0000000000001221

The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
Abraham, BP, Fan, C, Thurston, T, Moskow, J & Malaty, HM 2023, , Nutrients, vol. 15, no. 22, 4847. https://doi.org/10.3390/nu15224847, https://doi.org/10.3390/nu15224847

The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab
Abraham, BP, Fan, C, Thurston, T, Moskow, J & Malaty, HM 2023, , Nutrients, vol. 15, no. 22, 4847. https://doi.org/10.3390/nu15224847

Real-World Impact of Infliximab Precision-Guided Dosing on Management of Patients With IBD
Abraham, BP, Ziring, DA, Dervieux, T, Han, PA, Shim, A & Battat, R 2023, , American Journal of Managed Care, vol. 29, no. 12 Suppl, pp. S227-S235. https://doi.org/10.37765/AJMC.2023.89447

The Role of Fecal Microbiota Transplantation in the Induction of Remission in Ulcerative Colitis
Saleh, A, Parsa, S, Garza, M, Quigley, EMM & Abraham, BP 2023, , Digestive Diseases, vol. 41, no. 4, pp. 656-665. https://doi.org/10.1159/000529591

Utility of Intestinal Ultrasound in Clinical Decision-Making for Inflammatory Bowel Disease
Saleh, A & Abraham, BP 2023, , Crohns and Colitis 360, vol. 5, no. 3, otad027, pp. otad027. https://doi.org/10.1093/crocol/otad027

Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started
Abraham, BP, Reddy, D & Saleh, A 2023, , Crohns and Colitis 360, vol. 5, no. 3, otad043, pp. otad043. https://doi.org/10.1093/crocol/otad043

The Current State of Care for Black and Hispanic Inflammatory Bowel Disease Patients
Liu, JJ, Abraham, BP, Adamson, P, Barnes, EL, Brister, KA, Damas, OM, Glover, SC, Hooks, K, Ingram, A, Kaplan, GG, Loftus, EV, McGovern, DPB, Narain-Blackwel, M, Odufalu, FD, Quezada, S, Reeves, V, Shen, B, Stappenbeck, TS & Ward, L 2023, , Inflammatory bowel diseases, vol. 29, no. 2, pp. 297-307. https://doi.org/10.1093/ibd/izac124

Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease
Papamichael, K, Vande Casteele, N, Abraham, BP, Ritter, T, Jain, A & Cheifetz, AS 2023, , Clinical Gastroenterology and Hepatology. https://doi.org/10.1016/j.cgh.2022.10.037

Clinical Evaluation of Upadacitinib in the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis (UC): Patient Selection and Reported Outcomes
Irani, M, Fan, C, Glassner, K & Abraham, BP 2023, , Clinical and Experimental Gastroenterology, vol. 16, pp. 21-28. https://doi.org/10.2147/CEG.S367086